Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00525837 · ClinicalTrials.gov registry record · NA
Study of Mood Effects of Varenicline (Chantix) in Depressed Outpatient Smokers
A NA study, sponsored by Butler Hospital.
- Completed
- Registry status
- NA
- Development phase
- 18
- Enrollment target
NCT00525837 is a NA study that has completed, run by Butler Hospital. The registered enrollment target is 18 participants.
The verdict
NCT00525837, a NA study, has completed, sponsored by Butler Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 18 participants
- Enrollment target
Study Summary
This study will assess whether varenicline (chantix) has antidepressant properties when used in addition to other psychiatric medication. It will also assess whether varenicline improves the inability to feel pleasure (i.e. anhedonia), and if it is well-tolerated when used with psychiatric medications. Enrolled patients will be assessed for improved mood, improved anhedonia, overall sense of health, side effects as well as tobacco use for 6-8 weeks. Medication will be provided free of charge.
Interventions
- DRUG varenicline
- DRUG fixed dose varenicline
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 18 participants |
| Start Date | 2007-09 |
| Est. Completion | 2008-03 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00525837
The ClinicalTrials.gov registry entry for NCT00525837 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 18 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Butler Hospital, which has 103 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which varenicline is the first listed.
NCT00525837 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00525837 about?
NCT00525837 is a clinical study titled "Study of Mood Effects of Varenicline (Chantix) in Depressed Outpatient Smokers". This study will assess whether varenicline (chantix) has antidepressant properties when used in addition to other psychiatric medication. It will also assess whether varenicline improves the inability to feel pleasure (i.e. anhedonia), and if it is well-tolerated when used with psychiatric medicatio...
What is the current status of trial NCT00525837?
This trial is currently completed. It is a NA study. The enrollment target is 18 participants. The study started on 2007-09. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00525837?
The interventions under investigation include: varenicline (DRUG), fixed dose varenicline (DRUG).
Who is sponsoring clinical trial NCT00525837?
This trial is sponsored by Butler Hospital, which has 103 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.